GNE-0439 is a novel, state-dependent Nav1.7 inhibitor (IC50=0.34 µM) with significant selectivity over Nav1.5. Its unique carboxylic acid moiety binds outside the pore, differentiating it from VSD4-targeting compounds. This tool compound is valuable for in vitro electrophysiology and pain research to study sodium channel pharmacology and gating mechanisms.